| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 107097-79-0 | 甲苯磺酸妥舒沙星; 7-(3-氨基吡咯烷-1-基)-1-(2,4-二氟苯基)-6-氟-1,4-二氫-4-氧-1,8-萘啶-3-羧酸對甲苯磺酸 | Tosufloxacin tosilate; 7-(3-Aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid 4-methylbenzenesulfonate hydrate |  | C26H25F3N4O7S | 詳情 | 供應(yīng)商 |
| 108138-46-1 | 托氟沙星; 7-(3-氨基吡咯烷-1-基)-1-(2,4-二氟苯基)-6-氟-4-氧代-1,8-萘啶-3-羧酸 | Tosufloxacin; 7-(3-Aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid |  | C19H15F3N4O3 | 詳情 | 供應(yīng)商 |
| 115964-29-9 | 甲苯磺酸妥舒沙星; 甲苯磺酸托氟沙星; 7-(3-氨基吡咯烷-1-基)-1-(2,4-二氟苯基)-6-氟-4-氧代-1,8-萘啶-3-甲酸 | Tosufloxacin tosylate; 7-(3-Aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid 4-methylbenzenesulfonate |  | C26H23F3N4O6S | 詳情 | 供應(yīng)商 |
| 125051-32-3 | 雙(1-(2,4-二氟苯基)-3-吡咯基)二茂鈦 | Titanium, bis(h5-2,4-cyclopentadien-1-yl)bis[2,6-difluoro-3-(1H-pyrrol-1-yl)phenyl]-; 1H-Pyrrole,1-(2,4-difluorophenyl)-, titanium complex; Bis h5-2,4-cyclopentadien-1-yl)bis(2,6-difluoro-3-(1H-pyrrol-1-yl)phenyl)titanium; Bis(cyclopentadienyl)-bis[2,6-difluoro-3-(pyrrol-1-yl)-phenyl]titaninum; Bis(h5-cyclopentadien-1-yl)-bis[2,6-difluoro-3-(1H-pyrrol-1-yl)phenyl]titanium; CGI 784; Dicyclopentadienylbis[2,6-difluoro-3-(1-pyrrolyl)phenyl]titanium; IC784; IRG 784; Irgacure 784 |  | C30H22F4N2Ti | 詳情 | 供應(yīng)商 |
| 918505-84-7 | N-[3-[(5-氯-1H-吡咯并[2,3-B]吡啶-3-基)羰基]-2,4-二氟苯基]-1-丙磺酰胺; N-[3-[(5-氯-1H-吡咯并[2,3-B]吡? | N-[3-[(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl]-1-propanesulfonamide; N-[3-[(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl]-1-propanesulfonamide; PLX-4720; N-(3-(5-Chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide |  | C17H14ClF2N3O3S | 詳情 | 供應(yīng)商 |
| 845256-65-7 | (2S)-4-(2,5-二氟苯基)-N-[(3R,4S)-3-氟-1-甲基-4-哌啶基]-2,5-二氫-2-羥基甲基-N-甲基-2-苯基-1H-吡咯-1-? | ALR-3456; ALR-3456; 1H-Pyrrole-1-carboxamide, 4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methyl-4-piperidinyl]-2,5-dihydro-2-(hydroxymethyl)-N-methyl-2-phenyl-, (2S)-; MK0731; (R)-2-aMino-2-cyclopropyl-1-((S)-4-(2,5-difluorophenyl)-2-phenyl-2H-pyrrol-1(5H)-yl)ethanone |  | C25H28F3N3O2 | 詳情 | 供應(yīng)商 |
| 100490-36-6 | 甲苯磺酸妥舒沙星; 諾托氟沙星; (+)-7-(3-氨基-1-吡咯烷基)-6-氟-1-(2,4-二氟苯基)-1,4-二氫-4-氧代-1,8-萘啶 | TOSUFLOXACIN TOSILATE; 1,8-naphthyridine-3-carboxylicacid,1,4-dihydro-7-(3-amino-1-pyrrolidinyl)-1-(; 4-difluorophenyl)-6-fluoro-4-oxo-; a61827; a67107; abbott61827; 1-(2,4-Difluorophenyl)-6-fluoro-1,4-dihydro-7-(3-aminopyrrolidin-1-yl)-4-oxo-1,8-naphthyridine-3-carboxylic acid; 1,8-Naphthyridine-3-carboxylic acid, 7-(3-amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo- (9CI); (+)-7-(3-Amino-1-pyrrolidinyl)-6-fluoro-1-(2，4-difluo-rophenyl)-1，4-dihydrcr-4-oxo-1，8-naphthyridine-3-carboxyli cacid |  | 詳情 | 供應(yīng)商 | |
| 957118-49-9 | (8R)-8-(3,5-二氟苯基)-10-氧代-N-[(2R)-1,1',2',3-四氫-2'-氧代螺[2H-茚-2,3'-[3H]吡咯并[2,3-B]吡啶]-5-基]-6,9-二氮雜螺[4.5]癸烷-9-乙酰胺; (8R)-8-(3,5-二氟苯基)-10-氧代-N-[(2R)-1,1',2',3-四氫-2'-氧代螺[2H-茚-2,3'-[3H]吡咯并[2,3-B]吡啶]-5-基]-6,9-二氮雜螺[4.5]癸烷-9-乙酰胺 | (8R)-8-(3,5-Difluorophenyl)-10-oxo-N-[(2R)-1,1',2',3-tetrahydro-2'-oxospiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-6,9-diazaspiro[4.5]decane-9-acetamide; (8R)-8-(3,5-Difluorophenyl)-10-oxo-N-[(2R)-1,1',2',3-tetrahydro-2'-oxospiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-6,9-diazaspiro[4.5]decane-9-acetamide; MK 3207; 6,9-Diazaspiro[4.5]decane-9-acetaMide,8-(3,5-difluorophenyl)-10-oxo-N-[(2R)-1,1',2',3-tetrahydro-2'-oxospiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-,(8R)- |  | C31H29F2N5O3 | 詳情 | 供應(yīng)商 |
| 1218935-59-1 | (R)-2-(2,5-二氟苯基)吡咯烷 | (R)-2-(2,5-difluorophenyl)pyrrolidine | 無 | 詳情 | 供應(yīng)商 |